17Jul 2024
Imiquimod for the treatment of oral leukoplakia

Imiquimod for the treatment of oral leukoplakia

The retrospective study assessed topical 5% imiquimod for oral leukoplakia, finding that 68.4% of lesions had a ≥50% size reduction. Common adverse events were local site reactions and fatigue. Prospective studies are needed to confirm effectiveness.

  • #dentistry

Like

Save

Share